BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 11175361)

  • 1. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Ets transcription factors and targets in osteoblast differentiation and matrix mineralization.
    Vary CP; Li V; Raouf A; Kitching R; Kola I; Franceschi C; Venanzoni M; Seth A
    Exp Cell Res; 2000 May; 257(1):213-22. PubMed ID: 10854070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ets2 transcription factor inhibits mineralization and affects target gene expression during osteoblast maturation.
    Li V; Raouf A; Kitching R; Seth A
    In Vivo; 2004; 18(5):517-24. PubMed ID: 15523888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
    Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
    Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RING finger protein RNF11 is expressed in bone cells during osteogenesis and is regulated by Ets1.
    Gao Y; Ganss BW; Wang H; Kitching RE; Seth A
    Exp Cell Res; 2005 Mar; 304(1):127-35. PubMed ID: 15707580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models in the study of the Ets family of transcription factors.
    Bartel FO; Higuchi T; Spyropoulos DD
    Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter.
    Raouf A; Li V; Kola I; Watson DK; Seth A
    Oncogene; 2000 Apr; 19(15):1969-74. PubMed ID: 10773887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
    Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
    Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
    Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
    Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of the chromosome 21 transcription factor Ets2 in cell-seeded three-dimensional bone constructs.
    Turhani D; Watzinger E; Weissenböck M; Yerit K; Cvikl B; Ewers R; Thurnher D
    J Biomed Mater Res A; 2005 Jun; 73(4):445-55. PubMed ID: 15900611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction and the Ets family of transcription factors.
    Yordy JS; Muise-Helmericks RC
    Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
    Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the ets genes and their products.
    Watson DK; Ascione R; Papas TS
    Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.
    Quarles LD; Yohay DA; Lever LW; Caton R; Wenstrup RJ
    J Bone Miner Res; 1992 Jun; 7(6):683-92. PubMed ID: 1414487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene.
    Fen JQ; Zhang J; Dallas SL; Lu Y; Chen S; Tan X; Owen M; Harris SE; MacDougall M
    J Bone Miner Res; 2002 Oct; 17(10):1822-31. PubMed ID: 12369786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
    Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
    J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
    Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
    J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.